Novo Nordisk, the producer of Wegovy, said it "offers counseling and follow-up as part of its trials, helping some patients on placebo make lifestyle changes and lose weight as well," according to Bloomberg
boulardii , L
The challenges: GLP-1s can also: Slow gastric emptying, which increases operative risks Cause slower wound healing if nutritional intake is low Lead to muscle loss, which can reduce recovery strength Continue to suppress appetite during a period where nutrition is critical Some surgeons require: A pause before surgery (often 24 weeks) Evidence of stable nutrition A personalised post-operative plan to avoid nausea and ensure adequate protein intake In short, GLP-1s can help, but they must be used mindfully and usually require a pre- and post-surgery strategy with your healthcare provider
Each session emphasizes foundational movement patterns with progressive resistance and controlled tempo to drive strength and performance in a highly efficient 10 minute format
Do not open vials in humid environments
In SURMOUNT-5, patients on tirzepatide lost an average of 20.2% of their body weight over 72 weeks (about 50 pounds for a 250-pound person), compared to 13.7% (about 33 pounds) with semaglutide